Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Deloitte Haskins quits...

    Deloitte Haskins quits as Fortis statutory auditor

    Farhat NasimWritten by Farhat Nasim Published On 2019-01-01T11:46:17+05:30  |  Updated On 1 Jan 2019 11:46 AM IST
    Deloitte Haskins quits as Fortis statutory auditor


    "The aforesaid matter was discussed with the statutory auditors of the company - Deloitte Haskins and Sells LLP. After due consideration, the auditors have tendered their resignation with effect from December 28, 2018," it added.


    New Delhi: Fortis Healthcare Saturday said its statutory auditor Deloitte Haskins and Sells LLP has tendered resignation as the company's largest shareholder Malaysian firm IHH prefers to align its auditors on a group-wide basis. "Pursuant to the issuance of 235,294,117 equity shares to Northern TK ventures Pte Limited, a subsidiary of IHH, IHH has become the largest shareholder in the company," Fortis Healthcare said in a filing to the BSE.



    Post induction of additional nominee directors of IHH on the boards of the company, IHH prefers to align its auditors on a group-wide basis, it added.

    "This may lead to streamlining the audit process and also bring inefficiencies from a cost and time perspective," Fortis Healthcare said.

    "The aforesaid matter was discussed with the statutory auditors of the company - Deloitte Haskins and Sells LLP. After due consideration, the auditors have tendered their resignation with effect from December 28, 2018," it added.

    Earlier in November this year, Fortis had announced issuing of 23.53 crore equity shares through preferential allotment to IHH Healthcare Berhad for around Rs 4,000 crore, a move that helped the Malaysian firm take 31.1 per cent stake in the company.




    Also Read: Fortis Healthcare appoints Shirish Moreshwar Apte as vice-chairman
    Deloitte Haskinsequity sharesFHLFortisFortis Healthcarehospital chainsIHH HealthcareLLPMalaysian firmNorthern TK ventures Ptestatutory auditor
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok